<?xml version="1.0" encoding="UTF-8"?>
<ref id="B180-vaccines-08-00224">
 <label>180.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Arabi</surname>
    <given-names>Y.M.</given-names>
   </name>
   <name>
    <surname>Shalhoub</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Mandourah</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Al-Hameed</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Al-Omari</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Al Qasim</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Jose</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Alraddadi</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Almotairi</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Al Khatib</surname>
    <given-names>K.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Ribavirin and Interferon Therapy for Critically Ill Patients with Middle East Respiratory Syndrome: A Multicenter Observational Study</article-title>
  <source>Clin. Infect. Dis.</source>
  <year>2020</year>
  <volume>70</volume>
  <fpage>1837</fpage>
  <lpage>1844</lpage>
  <pub-id pub-id-type="doi">10.1093/cid/ciz544</pub-id>
  <pub-id pub-id-type="pmid">31925415</pub-id>
 </element-citation>
</ref>
